Charlotte Gineste

Illkirch-graffenstaden, 67404, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Integrative Multi-Omics and Network Analyses Reveal Pathogenic and Protective Pathways in Centronuclear Myopathies.

Integrative Multi-Omics and Network Analyses Reveal Pathogenic and Protective Pathways in Centronuclear Myopathies.

Journal: International journal of molecular sciences

Published: September 11, 2025

Myosin inhibition partially rescues the myofiber proteome in X-linked myotubular myopathy.

Myosin inhibition partially rescues the myofiber proteome in X-linked myotubular myopathy.

Journal: JCI insight

Published: May 07, 2025

Tamoxifen treatment fails to improve muscle dysfunction in a model of recessive RYR1-linked centronuclear myopathy.

Tamoxifen treatment fails to improve muscle dysfunction in a model of recessive RYR1-linked centronuclear myopathy.

Journal: Disease models & mechanisms

Published: May 02, 2025

Tamoxifen, a high-potential molecule to treat all centronuclear myopathies

Tamoxifen, a high-potential molecule to treat all centronuclear myopathies

Journal: Medecine sciences : M/S

Published: November 18, 2024

Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function.

Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function.

Journal: Science (New York, N.Y.)

Published: October 24, 2024

Cyclosporine A Delays the Terminal Disease Stage in the Tfam KO Mitochondrial Myopathy Mouse Model Without Improving Mitochondrial Energy Production.

Cyclosporine A Delays the Terminal Disease Stage in the Tfam KO Mitochondrial Myopathy Mouse Model Without Improving Mitochondrial Energy Production.

Journal: Muscle & nerve

Published: January 17, 2024

Tirasemtiv enhances submaximal muscle tension in an Acta1:p.Asp286Gly mouse model of nemaline myopathy.

Tirasemtiv enhances submaximal muscle tension in an Acta1:p.Asp286Gly mouse model of nemaline myopathy.

Journal: The Journal of general physiology

Published: August 22, 2023

Therapeutic approaches in different congenital myopathies.

Therapeutic approaches in different congenital myopathies.

Journal: Current opinion in pharmacology

Published: August 24, 2022

Enzymatically dissociated muscle fibers display rapid dedifferentiation and impaired mitochondrial calcium control.

Enzymatically dissociated muscle fibers display rapid dedifferentiation and impaired mitochondrial calcium control.

Journal: iScience

Published: April 12, 2022

Tamoxifen improves muscle structure and function of Bin1- and Dnm2-related centronuclear myopathies.

Tamoxifen improves muscle structure and function of Bin1- and Dnm2-related centronuclear myopathies.

Journal: Brain : a journal of neurology

Published: October 08, 2021

Impaired aerobic capacity and premature fatigue preceding muscle weakness in the skeletal muscle Tfam-knockout mouse model.

Impaired aerobic capacity and premature fatigue preceding muscle weakness in the skeletal muscle Tfam-knockout mouse model.

Journal: Disease models & mechanisms

Published: February 24, 2021

Acute and chronic tirasemtiv treatment improves in vivo and in vitro muscle performance in actin-based nemaline myopathy mice.

Acute and chronic tirasemtiv treatment improves in vivo and in vitro muscle performance in actin-based nemaline myopathy mice.

Journal: Human molecular genetics

Published: December 21, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026